Stirring reactor (100 liter) for upscaling of laboratory syntheses, equipped with in-situ analysis for particle size measurement to monitor and control processes. (Picture: K. Dobberke für Fraunhofer ISC)
Nanoparticle à la Carte

Open Access Infrastructure for Pilot Line of Nano Particle and Nano-Composites

“What opportunities does the nanotechnology provide in general, provide nanoparticles for my products and processes?” So far, this question cannot be answered easily. Preparation and modification of nanoparticles and the further processing require special technical infrastructure and complex knowledge. For small and medium businesses the construction of this infrastructure “just on luck” is often not worth it. Even large companies shy away from the risks. As a result many good ideas just stay in the drawer.

Read on
With this divestment, Lonza plans to exit both softgels and liquid-filled hard capsules for the pharma market. (Lonza 	)
Pharma Deal

Lonza to Sell Two Production Sites to Nextpharma

Nextpharma will be acquiring two of Lonza’s production sites located in Ploermel, France and Edinburgh in the UK respectively. Both the sites produce liquid-filled hard capsules as well as softgels and with this deal Nextpharma intends to develop its technology for lipid based finished dosage forms.

Read on